Is the WiseTech share price horribly overvalued?

Can this stock deliver for investors?

| More on:
A man looking at his laptop and thinking.

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

The WiseTech Global Ltd (ASX: WTC) share price has done fabulously well for long-term investors. In just the past five years it has risen by more than 260%.

There aren't many S&P/ASX 200 Index (ASX: XJO) shares that have done as well as WiseTech shares in the last few years.

As we can see on the chart above the company has seen plenty of volatility in the last few years, and it's down close to 20% from the peak in 2023.

However, with the price/earnings (P/E) ratio still above 100 at the current WiseTech share price, it's worth asking the question about whether this ASX tech share is significantly overpriced.

Strong growth tailwinds

The company describes itself as a leading developer and provider of software solutions to the logistics execution industry globally. Its customers include over 17,000 of the world's logistics companies across 174 companies, including 44 of the top 50 global third-party logistics providers and 24 of the 25 largest global freight forwarders worldwide.

Its software, CargoWise, has become an essential part of the global logistics infrastructure.

I think the amount of global goods moving around the world is going to increase in the next few years, even if that's just from the increasing global population.

With more e-commerce, an evolving global supply chain and more people entering the middle class, I think the company has a good growth outlook.

In FY23, the company saw total revenue growth of 29% to $816.8 million, with CargoWise revenue up 41% to $659.6 million thanks to increased usage by existing customers and new customer signings. In the 2023 financial year, 96% of its revenue was recurring, and it lost less than 1% of its customers. The growth rate can have a major effect on the WiseTech share price.

It seems the business is extremely popular with existing customers (who keep spending more) and its revenue base is increasing.

In FY24, revenue is expected to grow by between 27% to 34%, up to $1.1 billion. CargoWise revenue could grow by between 34% to 43%.

Profit margins impacted

Earnings before interest, tax, depreciation and amortisation (EBITDA) in FY24 is expected to grow by between 18% to 27% to between $455 million to $490 million, which is slower than the revenue growth.

Software is normally very scalable – once the software has been developed, additional users are a bonus and should largely help boost margins.

So, why is FY24 going to see slower profit growth?

There are the recent small acquisitions of MatchBox Exchange and Sistemas Casa and their associated upfront acquisition costs. Integrating acquisitions takes time and costs. It's expecting EBITDA margins to return to above 50% in FY26.

Does the WiseTech share price make sense?

The company is valued at around 110 times FY23's estimated earnings. That's a very high price/earnings (P/E) ratio compared to most businesses. But, if the company keeps growing profit strongly, then the valuation could quickly make sense.

On Commsec, the earnings per share (EPS) is projected to rise to $1.10 in FY25 and $1.46 in FY26. This would put the WiseTech share price at 64 times FY25's estimated earnings and 48 times FY26's estimated earnings.

If WiseTech's profit keeps growing at a strong double-digit rate over the coming years, today's price could seem cheap in five years.

A lot of that growth though, is already expected by the market, which is why it's priced as highly as it is. But I wouldn't call it horribly overvalued based on its economics and long-term growth outlook.

I'm not sure I can argue it's cheap today, particularly in this high interest rate era. But, I don't think it's horribly overvalued. Over the past decade, Microsoft, Alphabet and Meta Platforms have been called overvalued a lot, yet they kept rising as earnings justified the higher share prices.

WiseTech seems to be one of the very best businesses on the ASX, but it's certainly possible the WiseTech share price could become better value during 2024.

Randi Zuckerberg, a former director of market development and spokeswoman for Facebook and sister to Meta Platforms CEO Mark Zuckerberg, is a member of The Motley Fool's board of directors. Suzanne Frey, an executive at Alphabet, is a member of The Motley Fool’s board of directors. Motley Fool contributor Tristan Harrison has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has positions in and has recommended Alphabet, Meta Platforms, Microsoft, and WiseTech Global. The Motley Fool Australia has positions in and has recommended WiseTech Global. The Motley Fool Australia has recommended Alphabet and Meta Platforms. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Opinions

a hand reaches out with australian banknotes of various denominations fanned out.
Dividend Investing

These 2 ASX dividend shares are great buys right now

These defensive names look like strong picks today.

Read more »

Four piles of coins, each getting higher, with trees on them.
Growth Shares

2 ASX 200 shares that could be top buys for growth

These two businesses have an exciting future.

Read more »

Two IT professionals walk along a wall of mainframes in a data centre discussing various things
Technology Shares

This ASX 200 share is being labelled one of the market's most undervalued by brokers

NextDC shares have pulled back sharply, but brokers believe the long-term growth story remains firmly on track.

Read more »

Hand holding out coal in front of a coal mine.
Energy Shares

Up 25% in 2025: Is Whitehaven Coal still a buy?

After a strong 25% run this year, investors are asking whether Whitehaven Coal still has more upside left.

Read more »

Five guys in suits wearing brightly coloured masks, they are corporate superheroes.
Opinions

5 ASX shares I'd buy with $10,000 this week

These are the ASX stocks I have my eye on this week.

Read more »

bull market model with a bull looking at a rising chart
Opinions

By December 2026, $1,000 invested in EOS shares could be worth…

With its share price taking off and contracts piling up, EOS is shaping up as one of the most compelling…

Read more »

A doctor or medical expert in COVID protection adjusts her glasses, indicating growth or strong share price movement in ASX medical, biotech and health companies
Opinions

Forget CSL shares, I'd buy this booming biotech stock instead

This ASX biotech stock has caught my eye this year.

Read more »

A medical researcher rests his forehead on his fist with a dejected look on his face while sitting behind a scientific microscope with another researcher's hand on his shoulder as if giving comfort.
Healthcare Shares

Telix Pharmaceuticals shares crash 58% from their peak: Buying opportunity or time to sell up?

The biopharmaceutical company's shares are tipped to soar next year.

Read more »